IL6 and rheumatoid arthritis: However, this observational study is small (120 participants), had large numbers of patient stopping or switching therapy (60% switching biological therapy) and may be susceptible to confounding factors (patients receiving IL‐6 inhibition were older and had rheumatoid arthritis for longer).20